Opus Genetics Inc.

NASDAQ: IRD · Real-Time Price · USD
1.16
0.05 (4.50%)
At close: Aug 20, 2025, 1:23 PM

Opus Genetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
15.42M 13.65M 10.99M 8.38M 16.45M 19.01M 19.05M 57.21M 45.27M 41.6M 39.85M n/a 489K 589K 589K 589K 100K n/a
Cost of Revenue
23K 23K 10K 3K 4K 4K 4K 1K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
12.53M 13.64M 10.98M 8.38M 16.45M 19.01M 19.05M 57.21M 45.27M 41.6M 39.85M n/a 489K 589K 589K 589K 100K n/a
Operating Income
-64.87M -64.3M -62.07M -29.47M -15.08M -12.14M -10.56M 29.08M 18.15M 18.6M 18.23M -22.13M -21.83M -24.03M -22.7M -30.58M -28.29M -22.42M
Interest Income
500K 1.06M 1.66M 1.66M 1.16M 600K 367K 367K 367K 367K n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-58.27M -58.62M -57.53M -27.19M -14.09M -11.29M -9.97M 29.08M 18.97M 19.01M 18.2M -22.37M -22.07M -24.27M -56.69M -69.06M -66.08M -60.55M
Net Income
-58.27M -58.62M -57.53M -27.19M -14.11M -11.3M -9.99M 28.75M 18.66M 18.69M 17.89M -22.37M -22.07M -24.27M -56.69M -69.06M -66.08M -60.55M
Selling & General & Admin
22.3M 19.89M 18.21M 14.2M 13.36M 14.34M 11.96M 10.73M 10.38M 7.82M 7.27M 6.63M 6.52M 8.15M 8.12M 8.02M 6.99M 4.13M
Research & Development
29.99M 30.05M 26.85M 23.66M 18.17M 16.81M 17.65M 17.4M 16.74M 15.18M 14.36M 15.51M 15.8M 16.46M 15.17M 14.77M 13.03M 9.91M
Other Expenses
28M 28M 28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 8.38M 8.38M 8.38M
Operating Expenses
80.29M 77.95M 73.07M 37.85M 31.53M 31.15M 29.61M 28.13M 27.12M 23M 21.62M 22.13M 22.32M 24.62M 23.29M 31.17M 28.39M 22.42M
Interest Expense
1.41M 1.37M n/a n/a 1.33M 1.33M 1.33M 1.33M n/a 4K 9K 11K 11K 7K 2K 5.42M 5.6M 6.29M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
80.29M 77.95M 73.07M 37.85M 31.53M 31.15M 29.61M 28.13M 27.12M 23M 21.62M 22.13M 22.32M 24.62M 23.29M 31.17M 28.39M 22.42M
Income Tax Expense
n/a n/a n/a -2K 12K 12K 12K 329K 315K 315K 315K n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
63.38M 33.88M 31.57M 26.15M 25.83M 24.52M 21.52M 21.45M 20.96M 20.94M 20.81M 20.5M 19.5M 18.89M 17.85M 16.93M 13.61M 10.92M
Shares Outstanding (Diluted)
63.38M 33.88M 31.57M 26.15M 25.83M 24.52M 22M 22.41M 20.96M 20.94M 21.48M 20.5M 19.5M 18.89M 17.85M 16.93M 13.61M 10.92M
EPS (Basic)
-1.76 -1.94 -1.99 -1.1 -0.55 -0.49 -0.48 1.37 0.89 0.88 0.81 -1.17 -1.2 -1.47 -4.69 -6.74 -6.67 -6.38
EPS (Diluted)
-1.76 -1.94 -1.99 -1.1 -0.56 -0.5 -0.49 1.31 0.84 0.83 0.76 -1.17 -1.2 -1.47 -4.69 -6.74 -6.67 -6.38
EBITDA
-58.37M -57.79M -58.69M -28.36M -13.93M -10.99M -9.41M 29.64M 18.21M 18.68M 18.22M -22.35M -22.05M -24.26M -56.69M -63.63M -60.47M -54.25M
EBIT
-56.94M -57.81M -58.7M -28.36M -13.93M -10.99M -9.41M 29.64M 18.2M 18.67M 18.21M -22.36M -22.05M -24.27M -56.69M -63.63M -60.47M -54.25M
Depreciation & Amortization
23K 23K 10K 3K 4K 5K 6K 4K 4K 4K 4K 4K 4K 4K 4K 4K 4K 4K